股本结构
单位：万股
| 公告日期 | 2024-09-30 | 2024-09-30 | 2024-05-20 | 2024-04-22 | 2024-05-20 | 2023-12-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 484.72 | 440.72 | 321.91 | 440.72 | 384.72 | 384.72 |
| 普通股本 | 14541.72 | 13221.72 | 9657.27 | 13221.72 | 11541.72 | 11541.66 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-09-25 | 2024-06-30 | 2024-05-14 | 2024-04-22 | 2023-12-31 | 2023-12-14 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：30
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-09-30 | 14541.72 | 未披露 | 定期报告 | 2024-09-25 |
| 2024-09-30 | 13221.72 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-05-20 | 9657.27 | 未披露 | 定期报告 | 2024-05-14 |
| 2024-04-22 | 13221.72 | 未披露 |
更多>>
Common stock offered 16,800,000 shares by the company
|
2024-04-22 |
| 2024-05-20 | 11541.72 | 未披露 | 定期报告 | 2023-12-31 |
| 2023-12-12 | 11541.66 | 未披露 |
更多>>
Genetic Technologies Limited announced its plans to effect: a share consolidation of its ordinary shares (the “Shares”) of one (1) for one hundred (100) existing Shares (the “Local Consolidation”).
|
2023-12-14 |
| 2023-02-07 | 1154165.81 | 未披露 |
更多>>
ordinary shares offered 2,307,693,000 shares by the company
|
2023-02-07 |
| 2022-08-30 | 923396.51 | 未披露 |
更多>>
From June 30, 2021 to June 30, 2022
Contributions of equity, net of transaction costs and tax
|
2022-06-30 |
| 2021-08-31 | 922609.01 | 未披露 | 定期报告 | 2021-08-31 |
| 2021-08-31 | 901672.67 | 未披露 |
更多>>
From June 30, 2020 to June 30, 2021
Shares issued during the year
|
2021-06-30 |
| 2021-01-25 | 901172.67 | 未披露 |
更多>>
1.Securities offered by the company pursuant to this prospectus supplement 750,000,000 ordinary shares.
2.The above is based on 8,261,726,743 ordinary shares outstanding as of January 21, 2021.
|
2021-01-25 |
| 2020-10-22 | 826172.67 | 未披露 | 定期报告 | 2020-10-01 |
| 2020-07-20 | 812877.97 | 未披露 |
更多>>
1.Securities offered by the company pursuant to this prospectus supplement 615,000,000 ordinary shares represented by 1,025,000 ADSs.
2.The above discussion and table are based on 7,513,779,743 ordinary shares outstanding as of July 15, 2020.
|
2020-07-20 |
| 2020-08-31 | 751377.97 | 未披露 |
更多>>
from June 30, 2019 to June 30, 2020
Issue of 1,125,000,000 Ordinary Shares at $0.004 (October 25, 2019)
Issue of 617,144,400 Ordinary Shares (1,028,574 ADS at US$1.75/ADS) (April 2, 2020)
Issue of 433,501,200 Ordinary Shares (722,502 ADS at US$2.00/ADS) (April 22, 2020)
Issue of 2,400,000,000 Ordinary Shares (3,500,000 ADS at US$2.00/ADS and 500,000 Pre funded warrants at US$1.9999/Warrant) (May 28, 2020)
|
2020-06-30 |
| 2020-04-22 | 511377.97 | 未披露 |
更多>>
1.Securities offered by us pursuant to this prospectus supplement 433,501,200 ordinary shares represented by 722,502 ADSs
2.The above discussion and table are based on 4,680,278,543 ordinary shares outstanding as of April 19, 2020
|
2020-04-22 |
| 2020-04-03 | 468027.85 | 未披露 |
更多>>
1.Securities offered by us pursuant to this prospectus supplement 617,144,400 ordinary shares represented by 1,028,574 ADSs
2.The above discussion and table are based on 4,063,134,143 ordinary shares outstanding as of March 31, 2020
|
2020-04-03 |
| 2020-02-27 | 406313.41 | 未披露 |
更多>>
from July 1, 2019 to December 9, 2019
Rights issue
|
2019-12-09 |
| 2019-10-03 | 293813.41 | 未披露 |
更多>>
From June 30, 2018 to June 30, 2019
Issued of 108,833,100 Ordinary Shares @ $0.0113 Shares issued as part of private placements
Issued of 100,000,000 Ordinary Shares @ $0.0135 (25 October 2018)
Issued of 72,596,869 Ordinary Shares @ $0.00676 (6 May 2019)
Issued of 221,421,450 Shares (1,476,143 ADS @ US$0.80/ADS) (23 May 2019)
|
2019-06-30 |
| 2019-05-23 | 271671.27 | 未披露 | 定期报告 | 2019-05-23 |
| 2017-10-31 | 243528.27 | 未披露 |
更多>>
From June 30, 2016 to June 30, 2017
Add: shares issued as part of private placements
|
2017-06-30 |
| 2016-08-31 | 171528.27 | 未披露 |
更多>>
From June 30, 2015 to November 13, 2015
Add: shares issued as part of the conversion of convertible notes
|
2015-11-13 |
| 2015-11-13 | 171419.16 | 未披露 |
更多>>
from June 30, 2014 to June 30, 2015
Add: shares issued as part of private placements
Add: shares issued as part of the conversion of convertible notes
Add: shares issued on exercise of options
Add: shares issued in relation to a share-based payment
Add/ (less): transaction costs on placement of shares
|
2015-06-30 |
| 2015-03-06 | 121419.17 | 未披露 | 定期报告 | 2015-03-06 |
| 2015-03-04 | 84860.18 | 未披露 |
更多>>
from June 30, 2014 to December 31, 2014
Add:shares issued as part of private placements
Add:shares issued as part of the conversion of convertible notes
Less:shares cancelled as part of the swap deal
|
2014-12-31 |
| 2014-10-29 | 61391.85 | 未披露 |
更多>>
from June 30, 2013 to June 30, 2014
Add:shares issued as part of private placements
Add:shares issued as part of the conversion of convertible notes
Less:shares cancelled as part of the swap deal
|
2014-06-30 |
| 2013-11-18 | 57269.41 | 未披露 | 定期报告 | 2013-11-18 |
| 2013-08-30 | 47547.18 | 未披露 |
更多>>
from June 30,2012 to June 30,2013
Add:shares issued during the year from the exercise of options
|
2013-06-30 |
| 2012-08-29 | 46477.18 | 未披露 |
更多>>
from January 1, 2012 to June 30,2012
Add:shares issued during the year as part of private placement
Add:shares issued during the year from the exercise of options
|
2012-06-30 |
| 2010-12-21 | 40460.52 | 未披露 |
更多>>
from June 30, 2009 to June 30, 2010
Add: shares issued during the year for cash (net of associated costs)
Add: shares issued during the year other than for cash
|
2010-06-30 |
| 2009-12-24 | 37464.48 | 未披露 | 定期报告 | 2009-06-30 |
| 2006-12-28 | 36238.99 | 未披露 |
更多>>
from June 30, 2005 to June 30, 2006
Issuance of ordinary shares at 32 cents to acquire patents
|
2006-06-30 |
| 2005-12-30 | 36236.99 | 未披露 |
更多>>
from June 30, 2004 to June 30, 2005
Issuance of common shares at 16 cents on exercise of Vendor options
Issuance of common shares at 40 cents on exercise of Staff options
Issuance of common shares at 37 cents on exercise of Staff options
|
2005-06-30 |
Common stock offered 16,800,000 shares by the company
Genetic Technologies Limited announced its plans to effect: a share consolidation of its ordinary shares (the “Shares”) of one (1) for one hundred (100) existing Shares (the “Local Consolidation”).
ordinary shares offered 2,307,693,000 shares by the company
From June 30, 2021 to June 30, 2022
Contributions of equity, net of transaction costs and tax
From June 30, 2020 to June 30, 2021
Shares issued during the year
1.Securities offered by the company pursuant to this prospectus supplement 750,000,000 ordinary shares.
2.The above is based on 8,261,726,743 ordinary shares outstanding as of January 21, 2021.
1.Securities offered by the company pursuant to this prospectus supplement 615,000,000 ordinary shares represented by 1,025,000 ADSs.
2.The above discussion and table are based on 7,513,779,743 ordinary shares outstanding as of July 15, 2020.
from June 30, 2019 to June 30, 2020
Issue of 1,125,000,000 Ordinary Shares at $0.004 (October 25, 2019)
Issue of 617,144,400 Ordinary Shares (1,028,574 ADS at US$1.75/ADS) (April 2, 2020)
Issue of 433,501,200 Ordinary Shares (722,502 ADS at US$2.00/ADS) (April 22, 2020)
Issue of 2,400,000,000 Ordinary Shares (3,500,000 ADS at US$2.00/ADS and 500,000 Pre funded warrants at US$1.9999/Warrant) (May 28, 2020)
1.Securities offered by us pursuant to this prospectus supplement 433,501,200 ordinary shares represented by 722,502 ADSs
2.The above discussion and table are based on 4,680,278,543 ordinary shares outstanding as of April 19, 2020
1.Securities offered by us pursuant to this prospectus supplement 617,144,400 ordinary shares represented by 1,028,574 ADSs
2.The above discussion and table are based on 4,063,134,143 ordinary shares outstanding as of March 31, 2020
from July 1, 2019 to December 9, 2019
Rights issue
From June 30, 2018 to June 30, 2019
Issued of 108,833,100 Ordinary Shares @ $0.0113 Shares issued as part of private placements
Issued of 100,000,000 Ordinary Shares @ $0.0135 (25 October 2018)
Issued of 72,596,869 Ordinary Shares @ $0.00676 (6 May 2019)
Issued of 221,421,450 Shares (1,476,143 ADS @ US$0.80/ADS) (23 May 2019)
From June 30, 2016 to June 30, 2017
Add: shares issued as part of private placements
From June 30, 2015 to November 13, 2015
Add: shares issued as part of the conversion of convertible notes
from June 30, 2014 to June 30, 2015
Add: shares issued as part of private placements
Add: shares issued as part of the conversion of convertible notes
Add: shares issued on exercise of options
Add: shares issued in relation to a share-based payment
Add/ (less): transaction costs on placement of shares
from June 30, 2014 to December 31, 2014
Add:shares issued as part of private placements
Add:shares issued as part of the conversion of convertible notes
Less:shares cancelled as part of the swap deal
from June 30, 2013 to June 30, 2014
Add:shares issued as part of private placements
Add:shares issued as part of the conversion of convertible notes
Less:shares cancelled as part of the swap deal
from June 30,2012 to June 30,2013
Add:shares issued during the year from the exercise of options
from January 1, 2012 to June 30,2012
Add:shares issued during the year as part of private placement
Add:shares issued during the year from the exercise of options
from June 30, 2009 to June 30, 2010
Add: shares issued during the year for cash (net of associated costs)
Add: shares issued during the year other than for cash
from June 30, 2005 to June 30, 2006
Issuance of ordinary shares at 32 cents to acquire patents
from June 30, 2004 to June 30, 2005
Issuance of common shares at 16 cents on exercise of Vendor options
Issuance of common shares at 40 cents on exercise of Staff options
Issuance of common shares at 37 cents on exercise of Staff options